Insulet Corporation (PODD) PT Raised to $63 at Cowen on 2Q Report; 'Direct Europe Commercialization Drives Sharp Upward Estimate Revisions'
Cowen raised its price target on Insulet Corporation (NASDAQ: PODD) to $63.00 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
